FAM221B
gene geneOn this page
Summary
FAM221B (family with sequence similarity 221 member B, HGNC:30762) is a protein-coding gene on chromosome 9p13.3, encoding Protein FAM221B (A6H8Z2).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_001012446
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30762 |
| Approved symbol | FAM221B |
| Name | family with sequence similarity 221 member B |
| Location | 9p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204930 |
| Ensembl biotype | protein_coding |
| Entrez | 392307 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 nonsense_mediated_decay
ENST00000377984, ENST00000388950, ENST00000423537, ENST00000472182
RefSeq mRNA: 1 — MANE Select: NM_001012446
NM_001012446
CCDS: CCDS43799
Canonical transcript exons
ENST00000423537 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001504486 | 35825230 | 35825373 |
| ENSE00001504487 | 35825564 | 35826161 |
| ENSE00001839847 | 35816391 | 35818506 |
| ENSE00001916764 | 35828463 | 35828732 |
| ENSE00003522049 | 35819890 | 35820000 |
| ENSE00003564168 | 35818890 | 35819009 |
| ENSE00003688702 | 35819197 | 35819394 |
Expression profiles
Bgee: expression breadth broad, 87 present calls, max score 83.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0309 / max 23.0053, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 100666 | 0.0309 | 3 |
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 83.89 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.85 | gold quality |
| left testis | UBERON:0004533 | 79.53 | gold quality |
| testis | UBERON:0000473 | 78.96 | gold quality |
| right testis | UBERON:0004534 | 78.58 | gold quality |
| quadriceps femoris | UBERON:0001377 | 66.43 | gold quality |
| cerebellar vermis | UBERON:0004720 | 64.61 | gold quality |
| right uterine tube | UBERON:0001302 | 60.77 | gold quality |
| granulocyte | CL:0000094 | 58.81 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 55.67 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 55.57 | gold quality |
| minor salivary gland | UBERON:0001830 | 55.52 | gold quality |
| bone marrow | UBERON:0002371 | 54.23 | gold quality |
| prostate gland | UBERON:0002367 | 53.52 | gold quality |
| rectum | UBERON:0001052 | 53.22 | gold quality |
| mucosa of stomach | UBERON:0001199 | 52.16 | gold quality |
| monocyte | CL:0000576 | 52.08 | gold quality |
| colonic epithelium | UBERON:0000397 | 51.90 | gold quality |
| leukocyte | CL:0000738 | 51.85 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 51.56 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 51.21 | silver quality |
| sural nerve | UBERON:0015488 | 50.40 | gold quality |
| muscle tissue | UBERON:0002385 | 49.90 | silver quality |
| spinal cord | UBERON:0002240 | 48.85 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 48.76 | gold quality |
| primary visual cortex | UBERON:0002436 | 48.57 | silver quality |
| cortical plate | UBERON:0005343 | 48.36 | silver quality |
| body of stomach | UBERON:0001161 | 46.88 | gold quality |
| urinary bladder | UBERON:0001255 | 46.36 | gold quality |
| stomach | UBERON:0000945 | 46.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.59 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting FAM221B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-1976 | 99.74 | 65.48 | 1127 |
| HSA-MIR-182-3P | 99.57 | 67.57 | 825 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-186-3P | 99.51 | 66.24 | 1685 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-548B-3P | 99.38 | 67.26 | 1000 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-877-3P | 99.09 | 68.10 | 1637 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-3124-3P | 98.87 | 68.95 | 2123 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam221b | ENSMUSG00000043633 |
| rattus_norvegicus | Fam221b | ENSRNOG00000025453 |
Paralogs (1): FAM221A (ENSG00000188732)
Protein
Protein identifiers
Protein FAM221B — A6H8Z2 (reviewed: A6H8Z2)
All UniProt accessions (3): A6H8Z2, C9JPK8, F8W8N9
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM221 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6H8Z2-1 | 1 | yes |
| A6H8Z2-2 | 2 | |
| A6H8Z2-3 | 3 |
RefSeq proteins (1): NP_001012448* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026755 | Fam221a/b | Family |
Pfam: PF14753
UniProt features (12 total): splice variant 4, compositionally biased region 3, region of interest 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6H8Z2-F1 | 64.61 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 30 (showing top):
chr9p13, NKX2_3_TARGET_GENES, ZNF223_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN, MIR4766_5P, MIR1236_3P, MIR597_3P, GSE11924_TH1_VS_TH2_CD4_TCELL_UP, MIR6748_3P, MIR574_5P, MIR3189_5P, HAY_BONE_MARROW_DENDRITIC_CELL, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_PANCREAS_MYELOID_CELLS, GSE2706_R848_VS_LPS_8H_STIM_DC_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
180 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM221B | TMEM202 | A6NGA9 | 646 |
| FAM221B | C7orf57 | Q8NEG2 | 527 |
| FAM221B | FNDC8 | Q8TC99 | 478 |
| FAM221B | CABCOCO1 | Q8IVU9 | 474 |
| FAM221B | SPAAR | A0A1B0GVQ0 | 446 |
| FAM221B | SPAG8 | Q99932 | 433 |
| FAM221B | SMIM33 | A0A1B0GW64 | 417 |
| FAM221B | TMEM8B | A6NDV4 | 415 |
| FAM221B | BPIFA3 | Q9BQP9 | 406 |
| FAM221B | RNF38 | Q9H0F5 | 374 |
| FAM221B | RNF17 | Q9BXT8 | 360 |
| FAM221B | SCP2D1 | Q9UJQ7 | 356 |
| FAM221B | TEX13A | Q9BXU3 | 336 |
| FAM221B | NPR2 | P20594 | 312 |
| FAM221B | SCN7A | Q01118 | 311 |
IntAct
46 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SELENOO | FAM221B | psi-mi:“MI:0915”(physical association) | 0.670 |
| FAM221B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| FAM221B | LCE2C | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | PLSCR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | EFHC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | LBX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | ANKRD11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | TRIM50 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | GSC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | CCDC13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | KPRP | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM221B | ATG13 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM221B | psi-mi:“MI:0915”(physical association) | 0.000 | |
| FAM221B | LCE2C | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | PLSCR2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | EFHC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | KPRP | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | KRT35 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM221B | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (30): RB1CC1 (Affinity Capture-MS), SMG6 (Affinity Capture-MS), ATG13 (Affinity Capture-MS), SELO (Affinity Capture-MS), EFNB3 (Affinity Capture-MS), ATG101 (Affinity Capture-MS), TSC2 (Affinity Capture-MS), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid), FAM221B (Two-hybrid)
ESM2 similar proteins: A2VCV0, A6H8Z2, A8T6P4, C3VD30, F6QRE9, P23497, P23804, P56950, Q00987, Q0P6D6, Q13342, Q1XFL1, Q32MH5, Q4JF29, Q5BLK4, Q5PQX1, Q5VYS8, Q5ZI58, Q60524, Q62187, Q66HD8, Q68FE6, Q69ZK7, Q6DRC5, Q6IE24, Q6NYJ3, Q6P752, Q6PCX9, Q70EL1, Q76N89, Q7L190, Q7T3T8, Q7T3T9, Q7YRZ8, Q7ZUW7, Q80UF7, Q8BL06, Q8BYU6, Q8C627, Q8C9M2
Diamond homologs: A6H8Z2, Q28J59, Q2VPL9, Q66HD8, Q8C627, A4D161, Q4V8D7, Q8C790
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
912 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:35818900:T:TA | donor_gain | 1.0000 |
| 9:35818903:T:TA | donor_gain | 0.9900 |
| 9:35819006:CAGC:C | acceptor_gain | 0.9900 |
| 9:35828461:AC:A | donor_gain | 0.9900 |
| 9:35828462:CC:C | donor_gain | 0.9900 |
| 9:35828462:CCCT:C | donor_gain | 0.9900 |
| 9:35818884:CCTCA:C | donor_loss | 0.9800 |
| 9:35818885:CTCAC:C | donor_loss | 0.9800 |
| 9:35818886:T:TC | donor_loss | 0.9800 |
| 9:35818887:C:CC | donor_loss | 0.9800 |
| 9:35818888:A:AG | donor_loss | 0.9800 |
| 9:35818889:C:CA | donor_loss | 0.9800 |
| 9:35819011:T:A | acceptor_loss | 0.9800 |
| 9:35819390:TATGT:T | acceptor_gain | 0.9800 |
| 9:35819392:TGT:T | acceptor_gain | 0.9800 |
| 9:35819395:C:CC | acceptor_gain | 0.9800 |
| 9:35819403:T:TC | acceptor_gain | 0.9800 |
| 9:35819997:AGACC:A | acceptor_loss | 0.9800 |
| 9:35819998:GACCT:G | acceptor_loss | 0.9800 |
| 9:35819999:ACC:A | acceptor_loss | 0.9800 |
| 9:35820000:CCTA:C | acceptor_loss | 0.9800 |
| 9:35820001:C:CA | acceptor_loss | 0.9800 |
| 9:35820002:T:A | acceptor_loss | 0.9800 |
| 9:35818638:T:C | donor_gain | 0.9700 |
| 9:35818888:A:AC | donor_gain | 0.9700 |
| 9:35818889:C:CC | donor_gain | 0.9700 |
| 9:35818889:CCG:C | donor_gain | 0.9700 |
| 9:35818969:C:CT | acceptor_gain | 0.9700 |
| 9:35819010:C:CC | acceptor_gain | 0.9700 |
| 9:35819021:G:GC | acceptor_gain | 0.9700 |
AlphaMissense
2643 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:35818978:G:C | F361L | 0.995 |
| 9:35818978:G:T | F361L | 0.995 |
| 9:35818980:A:G | F361L | 0.995 |
| 9:35819342:A:C | F302L | 0.995 |
| 9:35819342:A:T | F302L | 0.995 |
| 9:35819344:A:G | F302L | 0.995 |
| 9:35819348:G:C | F300L | 0.995 |
| 9:35819348:G:T | F300L | 0.995 |
| 9:35819350:A:G | F300L | 0.995 |
| 9:35818951:C:A | W370C | 0.994 |
| 9:35818951:C:G | W370C | 0.994 |
| 9:35818990:A:C | F357L | 0.994 |
| 9:35818990:A:T | F357L | 0.994 |
| 9:35818992:A:G | F357L | 0.994 |
| 9:35819270:C:A | W326C | 0.994 |
| 9:35819270:C:G | W326C | 0.994 |
| 9:35819272:A:G | W326R | 0.994 |
| 9:35819272:A:T | W326R | 0.994 |
| 9:35818953:A:G | W370R | 0.993 |
| 9:35818953:A:T | W370R | 0.993 |
| 9:35819285:A:C | F321L | 0.993 |
| 9:35819285:A:T | F321L | 0.993 |
| 9:35819287:A:G | F321L | 0.993 |
| 9:35819927:A:C | F272L | 0.993 |
| 9:35819927:A:T | F272L | 0.993 |
| 9:35819929:A:G | F272L | 0.993 |
| 9:35819984:C:A | W253C | 0.992 |
| 9:35819984:C:G | W253C | 0.992 |
| 9:35819986:A:G | W253R | 0.992 |
| 9:35819986:A:T | W253R | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000561440 (9:35818575 C>A,T), RS1000586371 (9:35824822 C>G,T), RS1000681310 (9:35824479 C>T), RS1000934989 (9:35818230 A>G), RS1001392684 (9:35826454 T>C), RS1001508162 (9:35816446 T>G), RS1001702239 (9:35823123 C>T), RS1002138757 (9:35823339 A>G), RS1002145115 (9:35828052 G>C), RS1002629484 (9:35825091 C>G), RS1002853094 (9:35822326 CCT>C), RS1003029377 (9:35829595 C>A,T), RS1003686426 (9:35817137 T>C), RS1003712765 (9:35820068 C>A,G), RS1003747524 (9:35816799 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009597_180 | Multiple sclerosis | 8.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.